Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
Background: Mitochondrial dysfunction has been identified as a pathophysiological hallmark of disease onset and progression in patients with Parkinsonian disorders. Besides the overall emergence of gene therapies in treating these patients, this highly relevant molecular concept has not yet been def...
Enregistré dans:
Auteurs principaux: | Jannik Prasuhn, Norbert Brüggemann |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cf8e89f6e60a4c4384145660bf062bf6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Gene Therapies for Monogenic Autism Spectrum Disorders
par: Wout Weuring, et autres
Publié: (2021) -
Applications of CRISPR-Cas Technologies to Proteomics
par: Georgii Dolgalev, et autres
Publié: (2021) -
Association of GAK rs1564282 With Susceptibility to Parkinson’s Disease in Chinese Populations
par: He Li, et autres
Publié: (2021) -
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
par: Amandine Billaud, et autres
Publié: (2021) -
Comparative Analysis of Complete Chloroplast Genomes of 13 Species in Epilobium, Circaea, and Chamaenerion and Insights Into Phylogenetic Relationships of Onagraceae
par: Yike Luo, et autres
Publié: (2021)